• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜透析患者中尿酸与心血管及全因死亡率的关联。

The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients.

作者信息

Dong Jie, Han Qing-Feng, Zhu Tong-Ying, Ren Ye-Ping, Chen Jiang-Hua, Zhao Hui-Ping, Chen Meng-Hua, Xu Rong, Wang Yue, Hao Chuan-Ming, Zhang Rui, Zhang Xiao-Hui, Wang Mei, Tian Na, Wang Hai-Yan

机构信息

Renal Division, Department of Medicine, Peking University First Hospital; Institute of Nephrology, Peking University; Key Laboratory of Renal Disease, Ministry of Health; Key Laboratory of Renal Disease, Ministry of Education; Beijing, China.

Department of Nephrology, Peking University Third Hospital, Beijing, China.

出版信息

PLoS One. 2014 Jan 8;9(1):e82342. doi: 10.1371/journal.pone.0082342. eCollection 2014.

DOI:10.1371/journal.pone.0082342
PMID:24416142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3885378/
Abstract

AIMS

To investigate whether uric acid (UA) is an independent predictor of cardiovascular (CV) and all-cause mortality in peritoneal dialysis (PD) patients after controlling for recognized CV risk factors.

METHODS

A total of 2264 patients on chronic PD were collected from seven centers affiliated with the Socioeconomic Status on the Outcome of Peritoneal Dialysis (SSOP) Study. All demographic and laboratory data were recorded at baseline. Multivariate Cox regression was used to calculate the hazard ratio (HR) of CV and all-cause mortality with adjustments for recognized traditional and uremia-related CV factors.

RESULTS

There were no significant differences in baseline characteristics between patients with (n = 2193) and without (n = 71) UA measured. Each 1 mg/dL of increase in UA was associated with higher all-cause mortality with 1.05(1.00∼1.10) of HR and higher CV mortality with 1.12 (1.05∼1.20) of HR after adjusting for age, gender and center size. The highest gender-specific tertile of UA predicted higher all-cause mortality with 1.23(1.00∼1.52) of HR and higher CV mortality with 1.69 (1.21∼2.38) of HR after adjusting for age, gender and center size. The predictive value of UA was stronger in patients younger than 65 years without CV disease or diabetes at baseline. The prognostic value of UA as both continuous and categorical variable weakened or disappeared after further adjusted for uremia-related and traditional CV risk factors.

CONCLUSIONS

The prognostic value of UA in CV and all-cause mortality was weak in PD patients generally, which was confounded by uremia-related and traditional CV risk factors.

摘要

目的

在控制公认的心血管风险因素后,研究尿酸(UA)是否为腹膜透析(PD)患者心血管(CV)和全因死亡率的独立预测因素。

方法

从腹膜透析结局社会经济地位(SSOP)研究的7个中心收集了总共2264例慢性PD患者。在基线时记录所有人口统计学和实验室数据。使用多变量Cox回归计算CV和全因死亡率的风险比(HR),并对公认的传统和尿毒症相关CV因素进行调整。

结果

测量了UA的患者(n = 2193)和未测量UA的患者(n = 71)之间的基线特征无显著差异。在校正年龄、性别和中心规模后,UA每增加1mg/dL与全因死亡率较高相关,HR为1.05(1.00~1.10),与CV死亡率较高相关,HR为1.12(1.05~1.20)。在校正年龄、性别和中心规模后,UA最高的特定性别三分位数预测全因死亡率较高,HR为1.23(1.00~1.52),CV死亡率较高,HR为1.69(1.21~2.38)。在基线时年龄小于65岁、无CV疾病或糖尿病的患者中,UA的预测价值更强。在进一步校正尿毒症相关和传统CV风险因素后,UA作为连续和分类变量的预后价值减弱或消失。

结论

一般而言,UA在PD患者的CV和全因死亡率中的预后价值较弱,这受到尿毒症相关和传统CV风险因素的混淆。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/cf13b9d40c8b/pone.0082342.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/76190f548486/pone.0082342.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/e236fbcedb86/pone.0082342.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/cf13b9d40c8b/pone.0082342.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/76190f548486/pone.0082342.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/e236fbcedb86/pone.0082342.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/3885378/cf13b9d40c8b/pone.0082342.g003.jpg

相似文献

1
The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients.腹膜透析患者中尿酸与心血管及全因死亡率的关联。
PLoS One. 2014 Jan 8;9(1):e82342. doi: 10.1371/journal.pone.0082342. eCollection 2014.
2
Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis.尿酸与高密度脂蛋白胆固醇比值可预测腹膜透析患者的心血管死亡率。
Nutr Metab Cardiovasc Dis. 2021 Feb 8;31(2):561-569. doi: 10.1016/j.numecd.2020.10.005. Epub 2020 Oct 15.
3
Serum uric acid predicts cardiovascular mortality in male peritoneal dialysis patients with diabetes.血清尿酸可预测男性糖尿病腹膜透析患者的心血管死亡率。
Nutr Metab Cardiovasc Dis. 2016 Jan;26(1):20-6. doi: 10.1016/j.numecd.2015.10.011. Epub 2015 Nov 17.
4
Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis.血清尿酸与腹膜透析患者全因和心血管死亡率的关系。
Am J Kidney Dis. 2014 Aug;64(2):257-64. doi: 10.1053/j.ajkd.2013.08.027. Epub 2013 Oct 28.
5
Correlation analysis of low-level serum uric acid and cardiovascular events in patients on peritoneal dialysis.血清尿酸水平与腹膜透析患者心血管事件的相关性分析。
Int Urol Nephrol. 2021 Nov;53(11):2399-2408. doi: 10.1007/s11255-021-02902-x. Epub 2021 Jun 8.
6
Effect of uric acid levels on mortality in Japanese peritoneal dialysis patients.尿酸水平对日本腹膜透析患者死亡率的影响。
Perit Dial Int. 2021 May;41(3):320-327. doi: 10.1177/0896860820929476. Epub 2020 Jun 5.
7
Low serum uric acid levels increase the risk of all-cause death and cardiovascular death in hemodialysis patients.低血清尿酸水平会增加血液透析患者全因死亡和心血管死亡的风险。
Ren Fail. 2020 Nov;42(1):315-322. doi: 10.1080/0886022X.2020.1745234.
8
Low Triiodothyronine Syndrome and Long-Term Cardiovascular Outcome in Incident Peritoneal Dialysis Patients.初发腹膜透析患者的低三碘甲状腺原氨酸综合征与长期心血管结局
Clin J Am Soc Nephrol. 2015 Jun 5;10(6):975-82. doi: 10.2215/CJN.03350414. Epub 2015 May 15.
9
Triglyceride to high-density lipoprotein cholesterol ratio is associated with increased mortality in older patients on peritoneal dialysis.甘油三酯与高密度脂蛋白胆固醇比值与腹膜透析老年患者死亡率升高相关。
Lipids Health Dis. 2019 Nov 15;18(1):199. doi: 10.1186/s12944-019-1147-8.
10
Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients.腹膜透析患者的非高密度脂蛋白胆固醇与死亡率。
J Clin Lipidol. 2021 Sep-Oct;15(5):732-742. doi: 10.1016/j.jacl.2021.06.005. Epub 2021 Jul 3.

引用本文的文献

1
Lower time-averaged serum uric acid was associated with increased mortality in peritoneal dialysis patients.腹膜透析患者较低的时间平均血清尿酸水平与死亡率增加相关。
Ther Apher Dial. 2025 Jun;29(3):479-490. doi: 10.1111/1744-9987.14252. Epub 2025 Feb 4.
2
Serum uric acid to creatinine ratio as a risk factor for mortality among patients on continuous ambulatory peritoneal dialysis: a multi-center retrospective study.血清尿酸与肌酐比值作为持续不卧床腹膜透析患者死亡率的危险因素:一项多中心回顾性研究。
Ren Fail. 2023;45(2):2273979. doi: 10.1080/0886022X.2023.2273979. Epub 2023 Oct 31.
3
The significance of follow-up serum uric acid levels in predicting all-cause mortality and cardiovascular mortality in peritoneal dialysis patients.

本文引用的文献

1
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.慢性肾脏病患者的西那卡塞:一项随机对照试验的累积荟萃分析。
PLoS Med. 2013;10(4):e1001436. doi: 10.1371/journal.pmed.1001436. Epub 2013 Apr 30.
2
Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort study.个体和环境社会经济地位对腹膜透析结局的影响:一项回顾性多中心队列研究。
PLoS One. 2012;7(11):e50766. doi: 10.1371/journal.pone.0050766. Epub 2012 Nov 30.
3
Antioxidants for chronic kidney disease.
随访血清尿酸水平对预测腹膜透析患者全因死亡率和心血管死亡率的意义。
Ther Apher Dial. 2023 Feb;27(1):83-90. doi: 10.1111/1744-9987.13892. Epub 2022 Jun 29.
4
Serum uric acid level and all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and dose-response meta-analysis of cohort studies.血清尿酸水平与腹膜透析患者的全因和心血管死亡率:队列研究的系统评价和剂量反应荟萃分析。
PLoS One. 2022 Feb 22;17(2):e0264340. doi: 10.1371/journal.pone.0264340. eCollection 2022.
5
Serum Uric Acid and Cardiovascular or All-Cause Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis.腹膜透析患者的血清尿酸与心血管或全因死亡率:一项系统评价和荟萃分析
Front Cardiovasc Med. 2021 Nov 3;8:751182. doi: 10.3389/fcvm.2021.751182. eCollection 2021.
6
Relationship between serum uric acid, all-cause mortality and cardiovascular mortality in peritoneal dialysis patients: systematic review and meta-analysis of cohort studies.血清尿酸与腹膜透析患者全因死亡率和心血管死亡率的关系:队列研究的系统评价和荟萃分析。
BMJ Open. 2021 Oct 18;11(10):e052274. doi: 10.1136/bmjopen-2021-052274.
7
Serum Uric Acid and Kidney Disease Measures Independently Predict Cardiovascular and Total Mortality: The Uric Acid Right for Heart Health (URRAH) Project.血清尿酸和肾脏疾病指标独立预测心血管疾病和全因死亡率:尿酸对心脏健康适宜性(URRAH)项目
Front Cardiovasc Med. 2021 Sep 27;8:713652. doi: 10.3389/fcvm.2021.713652. eCollection 2021.
8
High Serum Uric Acid and High-Sensitivity C Reactive Protein Concentrations Predict Three-Year Cardiovascular Mortality in Patients Treated With Continuous Ambulatory Peritoneal Dialysis.高血清尿酸和高敏C反应蛋白浓度可预测持续非卧床腹膜透析患者的三年心血管死亡率。
Cureus. 2021 Sep 12;13(9):e17900. doi: 10.7759/cureus.17900. eCollection 2021 Sep.
9
The prognosis and risk factors of baseline high peritoneal transporters on patients with peritoneal dialysis.基线高腹膜转运蛋白对腹膜透析患者预后和风险因素的影响。
J Cell Mol Med. 2021 Sep;25(18):8628-8644. doi: 10.1111/jcmm.16819. Epub 2021 Jul 26.
10
Risk factors for mortality in patients undergoing peritoneal dialysis: a systematic review and meta-analysis.腹膜透析患者死亡的风险因素:系统评价和荟萃分析。
Ren Fail. 2021 Dec;43(1):743-753. doi: 10.1080/0886022X.2021.1918558.
用于慢性肾病的抗氧化剂。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008176. doi: 10.1002/14651858.CD008176.pub2.
4
Serum uric acid independently predicts cardiovascular events in advanced nephropathy.血清尿酸独立预测晚期肾病中的心血管事件。
Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22.
5
Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality.血清尿酸水平对全因和心血管死亡率风险的意义。
Rheumatology (Oxford). 2013 Jan;52(1):127-34. doi: 10.1093/rheumatology/kes223. Epub 2012 Aug 25.
6
Risk factors for peripheral arterial disease among patients with chronic kidney disease.慢性肾脏病患者外周动脉疾病的风险因素。
Am J Cardiol. 2012 Jul 1;110(1):136-41. doi: 10.1016/j.amjcard.2012.02.061. Epub 2012 Mar 31.
7
Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.高尿酸血症与肾脏结局、心血管疾病和死亡率的关系。
Clin J Am Soc Nephrol. 2012 Apr;7(4):541-8. doi: 10.2215/CJN.09420911. Epub 2012 Feb 2.
8
Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.降低同型半胱氨酸治疗并不能减少慢性肾脏病患者的心血管结局:一项随机对照试验的荟萃分析。
Br J Nutr. 2012 Aug;108(3):400-7. doi: 10.1017/S0007114511007033. Epub 2012 Jan 16.
9
The association between plasma uric acid and renal function decline in a Chinese population-based cohort.中文人群队列研究中血浆尿酸与肾功能下降的关系。
Nephrol Dial Transplant. 2012 May;27(5):1836-9. doi: 10.1093/ndt/gfr597. Epub 2011 Oct 24.
10
Effect of the treatment with allopurinol on the endothelial function in patients with hyperuricemia.别嘌醇治疗对高尿酸血症患者内皮功能的影响。
Endocr Res. 2012;37(1):1-6. doi: 10.3109/07435800.2011.566235. Epub 2011 Oct 6.